PDF(1498 KB)
儿童型杆状体肌病2例临床、病理和基因研究
黄锟, 罗懿恩, 李秋香, 段卉茜, 毕方方, 杨欢, 罗月贝
中国当代儿科杂志 ›› 2018, Vol. 20 ›› Issue (10) : 804-808.
PDF(1498 KB)
PDF(1498 KB)
儿童型杆状体肌病2例临床、病理和基因研究
Clinical, pathological and genetic studies of two cases of childhood-onset nemaline myopathy
本文报道经肌肉病理及基因诊断确诊的儿童型杆状体肌病2例。2例患者均幼儿期起病，以肌肉无力为首发表现，病程长，进展缓慢。2例患者的肌肉病理光镜均发现Gomori染色及HE染色肌纤维胞浆内尤其肌膜下杆状物质沉积；电镜检查可见致密杆状体位于肌纤维肌膜下，与肌纤维长轴平行，部分肌纤维肌丝灶性溶解、坏死；基因检测发现两患儿分别存在杆状体肌病两种最常见的基因突变：ACTA1基因杂合突变（c.1013A > C）和NEB基因复合杂合突变（c.18676C > T及c.9812C > A）。杆状体肌病是一种常色体显性或隐性遗传的少见肌病，肌细胞胞浆中的杆状体是特征性肌肉病理改变。病理诊断和基因诊断是诊断杆状体肌病的金标准。
This article reports two cases of childhood-onset nemaline myopathy diagnosed by muscle pathology and genetic diagnosis. The two patients had onset in early childhood, with muscle weakness as the first manifestation, as well as long disease duration and slow progression. Gomori staining and hematoxylin-eosin staining showed redstained rods in the sarcoplasmic cytoplasm and sarcolemma under a light microscope. Electron microscopy showed that the dense nemaline rods were located under the muscle fiber sarcolemma and parallel to the long axis of the muscle fibers, and some muscle fiber myofilaments were dissolved and necrotic. Gene testing found that one of the two patients had heterozygous mutation (c.1013A > C) in the ACTA1 gene, and the other had compound heterozygous mutation (c.18676C > T and c.9812C > A) in the NEB gene. The two mutations were more common in nemaline myopathy. Nemaline myopathy is a recessive or dominant inheritance myopathy, in which the nemaline rod in the cytoplasm of myocytes is a characteristic muscle pathological change. Pathological and genetic diagnosis is the gold standard for diagnosis of nemaline myopathy.
Nemaline myopathy / Muscle biopsy / Nemaline rod / Genetic diagnosis
[1] Shy GM, Engel WK, Somers JE, et al. Nemaline myopathy. A new congenital myopathy[J]. Brain, 1963, 86(4):793-810.
[2] Schnitzler LJ, Schreckenbach T, Nadaj-Pakleza A, et al. Sporadic late-onset nemaline myopathy:clinico-pathological characteristics and review of 76 cases[J]. Orphanet J Rare Dis, 2017, 12(1):86.
[3] Wallgren-Pettersson C, Laing NG. Report of the 70th ENMC International Workshop:nemaline myopathy, 11-13 June 1999, Naarden, The Netherlands[J]. Neuromuscul Disord, 2000, 10(4-5):299-306.
[4] Monforte M, Primiano G, Silvestri G, et al. Sporadic late-onset nemaline myopathy:clinical, pathology and imaging findings in a single center cohort[J]. J Neurol, 2018, 265(3):542-551.
[5] Lee JM, Lim JG, Shin JH, et al. Clinical and genetic diversity of nemaline myopathy from a single neuromuscular center in Korea[J]. J Neurol Sci, 2017, 383:61-68.
[6] Joureau B, de Winter JM, Conijn S, et al. Dysfunctional sarcomere contractility contributes to muscle weakness in ACTA1-related nemaline myopathy (NEM3)[J]. Ann Neurol, 2018, 83(2):269-282.
[7] Malfatti E, Schaeffer U, Chapon F, et al. Combined cap disease and nemaline myopathy in the same patient caused by an autosomal dominant mutation in the TPM3 gene[J]. Neuromuscul Disord, 2013, 23(12):992-997.
[8] Mroczek M, Kabzinska D, Chrzanowska KH, et al. A novel TPM2 gene splice-site mutation causes severe congenital myopathy with arthrogryposis and dysmorphic features[J]. J Appl Genet, 2017, 58(2):199-203.
[9] Jungbluth H, Voermans NC. Congenital myopathies:not only a paediatric topic[J]. Curr Opin Neurol, 2016, 29(5):642-650.
[10] Park YE, Shin JH, Kang B, et al. NEB-related core-rod myopathy with distinct clinical and pathological features[J]. Muscle Nerve, 2016, 53(3):479-484.
[11] Laing NG, Dye DE, Wallgren-Pettersson C, et al. Mutations and polymorphisms of the skeletal muscle alpha-actin gene (ACTA1)[J]. Hum Mutat, 2009, 30(9):1267-1277.
[12] Lehtokari VL, Pelin K, Donner K, et al. Identification of a founder mutation in TPM3 in nemaline myopathy patients of Turkish origin[J]. Eur J Hum Genet, 2008, 16(9):1055-1061.
[13] Monnier N, Lunardi J, Marty I, et al. Absence of betatropomyosin is a new cause of Escobar syndrome associated with nemaline myopathy[J]. Neuromuscul Disord, 2009, 19(2):118-123.
[14] Amarasinghe C, Hossain MM, Jin JP. Functional basis of three new recessive mutations of slow skeletal muscle troponin T found in non-Amish TNNT1 nemaline myopathies[J]. Biochemistry, 2016, 55(32):4560-4567.
[15] Ockeloen CW, Gilhuis HJ, Pfundt R, et al. Congenital myopathy caused by a novel missense mutation in the CFL2 gene[J]. Neuromuscul Disord, 2012, 22(7):632-639.
[16] Seferian AM, Malfatti E, Bosson C, et al. Mild clinical presentation in KLHL40-related nemaline myopathy (NEM 8)[J]. Neuromuscul Disord, 2016, 26(10):712-716.
[17] Gupta VA, Ravenscroft G, Shaheen R, et al. Identification of KLHL41 mutations implicates BTB-Kelch-mediated ubiquitination as an alternate pathway to myofibrillar disruption in nemaline myopathy[J]. Am J Hum Genet, 2013, 93(6):1108-1117.
[18] Yuen M, Sandaradura SA, Dowling JJ, et al. Leiomodin-3 dysfunction results in thin filament disorganization and nemaline myopathy[J]. J Clin Invest, 2015, 125(1):456-457.
[19] Lornage X, Malfatti E, Cheraud C, et al. Recessive MYPN mutations cause cap myopathy with occasional nemaline rods[J]. Ann Neurol, 2017, 81(3):467-473.
[20] Malfatti E, Bohm J, Lacene E, et al. A premature stop codon in MYO18B is associated with severe nemaline myopathy with cardiomyopathy[J]. J Neuromuscul Dis, 2015, 2(3):219-227.
[21] Jungbluth H, Treves S, Zorzato F, et al. Congenital myopathies:disorders of excitation-contraction coupling and muscle contraction[J]. Nat Rev Neurol, 2018, 14(3):151-167.
[22] Agrawal PB, Strickland CD, Midgett C, et al. Heterogeneity of nemaline myopathy cases with skeletal muscle alpha-actin gene mutations[J]. Ann Neurol, 2004, 56(1):86-96.
[23] Findlay AR, Goyal NA, Mozaffar T. An overview of polymyositis and dermatomyositis[J]. Muscle Nerve, 2015, 51(5):638-656.
[24] Turner C, Hilton-Jones D. Myotonic dystrophy:diagnosis, management and new therapies[J]. Curr Opin Neurol, 2014, 27(5):599-606.
[25] Shah DU, Darras BT, Markowitz JA, et al. The spectrum of myotonic and myopathic disorders in a pediatric electromyography laboratory over 12 years[J]. Pediatr Neurol, 2012, 47(2):97-100.
[26] Scarpelli M, Todeschini A, Volonghi I, et al. Mitochondrial diseases:advances and issues[J]. Appl Clin Genet, 2017, 10:21-26.
[27] Voermans NC, Benveniste O, Minnema MC, et al. Sporadic late-onset nemaline myopathy with MGUS:long-term followup after melphalan and SCT[J]. Neurology, 2014, 83(23):2133-2139.
国家自然科学基金青年基金（81601094）。
